olmesartan medoxomil has been researched along with Dyslipidemia in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ahn, Y; Baek, SH; Choi, DH; Hong, TJ; Hyon, MS; Jeong, JO; Kang, WC; Kim, HS; Kim, SH; Kim, YH; Lee, SC; Nam, CW; Park, JS; Park, TH; Seo, HS; Shim, WJ; Shin, JH | 1 |
1 trial(s) available for olmesartan medoxomil and Dyslipidemia
Article | Year |
---|---|
Efficacy and safety of fixed-dose combination therapy with olmesartan medoxomil and rosuvastatin in Korean patients with mild to moderate hypertension and dyslipidemia: an 8-week, multicenter, randomized, double-blind, factorial-design study (OLSTA-D RCT:
Topics: Antihypertensive Agents; Double-Blind Method; Drug Combinations; Dyslipidemias; Female; Humans; Hypertension; Male; Middle Aged; Olmesartan Medoxomil; Republic of Korea; Rosuvastatin Calcium | 2016 |